Author (year) | Histology | Grade | Stage | Chemo | LND | Relapse site | Time to recurrence (months) | Status | OS (months) |
Watanabe et al (2020) | Serous | 1 | 1C3 | Yes | N/A | Pelvis | 40 | No evidence of disease | 119 |
Watanabe et al (2020) | Clear cell | High-grade | 1C3 | Yes | N/A | Pelvic LN | 55 | No evidence of disease | 107 |
Watanabe et al (2020) | Serous | 3 | 1C3 | Yes | N/A | Pelvis | 54 | Alive with disease | 104 |
Watanabe et al (2020) | Mucinous | 2 | 1C3 | No | N/A | Cervical LN | 17 | Dead of disease | 23 |
Jiang et al (2017)12 | Endometrioid | 3 | 1C3 | Yes | No | Contralateral ovary | 57.1 | No evidence of disease | N/A |
Jiang et al (2017)12 | Mucinous | 1 | 1C2 | Yes | No | Contralateral ovary | 9.2 | Alive with disease | N/A |
Jiang et al (2017)12 | Mucinous | 1 | 1C3 | Yes | No | Contralateral ovary | 16.3 | No evidence of disease | N/A |
Fruscio et al (2013)14 | Serous | 1 | 1C2 | No | Yes | Contralateral ovary | 118 | No evidence of disease | 194 |
Fruscio et al (2013)14 | Mucinous | 2 | 1C3 | Yes | Yes | Pelvis-abdomen | 25 | Dead of disease | 38 |
Fruscio et al (2013)14 | Serous | 2 | 1C3 | No | No | Pelvis-abdomen | 10 | Dead of disease | 23 |
Fruscio et al (2013)14 | Serous | 1 | 1C2 | Yes | No | Contralateral ovary | 19 | Alive with disease | 24 |
Fruscio et al (2013)14 | Mucinous | 1 | 1C3 | Yes | No | Contralateral ovary | 25 | No evidence of disease | 86 |
Fruscio et al (2013)14 | Clear cell | High-grade | 1C2 | Yes | No | Pelvis | 6 | Dead of disease | 17 |
Fruscio et al (2013)14 | Serous | 3 | 1C2 | Yes | No | LN | 65 | No evidence of disease | 208 |
Kashima et al (2013)15 | Mucinous | 1 | 1C3 | Yes | Yes | Right ovary | 14 | No evidence of disease | 114 |
Kashima et al (2013)15 | Serous | 1 | 1C2 | Yes | Yes | Brain | 15 | Dead of disease | 30 |
Kajiyama et al (2010)22 | Endometrioid | 1 | 1C3 | Yes | No | Intraperitoneal cavity | 5.2 | Dead of disease | 67.9 |
Kajiyama et al (2010) | Serous | 3 | 1C3 | Yes | No | Intraperitoneal cavity | 4.2 | Dead of disease | 6.7 |
Kajiyama et al (2010) | Endometrioid | 1 | 1C3 | Yes | No | Ovary | 128.5 | No evidence of disease | 128.5 |
Kajiyama et al (2010) | Mucinous | 1 | 1C2 | Yes | No | Intraperitoneal cavity | 9.3 | Dead of disease | 12.7 |
Satoh et al (2010)16 | Mucinous | 1 | 1C2 | Yes | N/A | Residual ovary | 43 | No evidence of disease | 16 |
Satoh et al (2010)16 | Endometrioid | 3 | 1C2 | Yes | N/A | N/A | 1 | Dead of disease | 5 |
Satoh et al (2010)16 | Serous | 1 | 1C3 | Yes | N/A | Peritoneum | 3 | Dead of disease | 22 |
Satoh et al (2010)16 | Clear cell | High-grade | 1C3 | No | N/A | Residual ovary, pelvic LN, peritoneum | 21 | Alive with disease | 29 |
Kajiyama et al (2008)23 | Clear cell | High-grade | 1C3 | Yes | No | Brain and pelvic/abdominal wall | 20.3 | Dead of disease | 36.8 |
Borgfeld et al (2007)18 | Mucinous | 3 | 1C3 | N/A | No | N/A | N/A | N/A | 16 |
Schilder et al (2002)17 | Serous/ endometrioid | 2 | 1C3 | Yes | No | Contralateral ovary | 8 | No evidence of disease | 18 |
Jobo et al (2000)19 | Mucinous | 1 | 1C2 | Yes | No | Contralateral ovary | 37 | Dead of disease | 78 |
LN, lymph node; LND, lymph node dissection; N/A, not available; OS, overall survival.